The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Anthony Tabiim
No Relationships to Disclose
 
Jabra Zarka
No Relationships to Disclose
 
Joanina Gicobi
No Relationships to Disclose
 
Nicole Becker
Employment - Mayo Clinic
 
Peter Rosen
No Relationships to Disclose
 
Miguel Muniz
No Relationships to Disclose
 
Elisabeth Heath
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Johnson & Johnson/Janssen; Sanofi; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Gilead Sciences; Novartis; Novartis; Sanofi
Speakers' Bureau - Sanofi
Research Funding - Arvinas (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BioXCel therapeutics (Inst); Bristol-Myers Squibb (Inst); Calibr (Inst); Calithera Biosciences (Inst); Caris Life Sciences (Inst); Corcept Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo Inc. (Inst); Eisai (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Fortis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITeos Therapeutics (Inst); Janssen Research & Development (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncolys BioPharma (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); POINT Biopharma (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Sanofi
Other Relationship - Caris Centers of Excellence
 
Oliver Sartor
Employment - Louisiana Cancer research center
 
Lance Pagliaro
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Regeneron (Inst)
 
Aadel Chaudhuri
Employment - Mayo Clinic
Leadership - CytoTrace Biosciences; Droplet Biosciences; LiquidCell Dx
Stock and Other Ownership Interests - CytoTrace Biosciences; Droplet Biosciences; Geneoscopy; LiquidCell Dx
Honoraria - Agilent; Illumina
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Caris Life Sciences (Inst); Geneoscopy; Guardant Health (Inst); Illumina; InVitae; Myriad Genetics; Roche
Research Funding - Tempus
Patents, Royalties, Other Intellectual Property - I have patent filings related to cancer biomarkers, and have received royalties related to licensed technology.
Travel, Accommodations, Expenses - Droplet Biosciences; LiquidCell Dx
Other Relationship - Illumina (Inst); Roche (Inst)
 
Daniel Childs
Employment - Mayo Clinic
Honoraria - Curio Science; DAVA Oncology; IDEOlogy Health; International Centers for Precision Oncology Foundation; IntrinsiQ; Mashup Media; MJH Life Sciences; Targeted Oncology
Consulting or Advisory Role - Abdera Thereapeutics (Inst); Janssen Biotech (Inst); Johnson & Johnson/Janssen (Inst); Novartis (Inst)
Research Funding - Janssen Biotech (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Prostate Cancer Foundation
 
John Cheville
No Relationships to Disclose
 
Fabrice Lucien
Consulting or Advisory Role - Mursla Bio
Research Funding - Early is Good; NaNotics
Patents, Royalties, Other Intellectual Property - FL discloses licensing agreement and royalties from Early is Good
 
Jeffrey Winters
Employment - Mayo Clinic
 
Jacob Orme
Employment - Mayo Clinic Cancer Center
Consulting or Advisory Role - NaNotics
Patents, Royalties, Other Intellectual Property - Patents regarding PD-L1 cleavage and immunotherapy resistance in multiple cancers. (Inst)